Roivant Sciences (ROIV) Invested Capital (2021 - 2024)

Roivant Sciences (ROIV) has 3 years of Invested Capital data on file, last reported at $40.0 million in Q2 2024.

• Quarterly Invested Capital changed 0.0% year-over-year to $40.0 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $40.0 million (down 91.4% YoY) and the FY2024 annual result came in at $40.0 million, changed 0.0% from the prior year.
• Invested Capital steadied at $40.0 million in Q2 2024, from $40.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $195.3 million in Q4 2023 to a low of $7.3 million in Q2 2022.
• A 3-year average of $80.0 million and a median of $40.0 million in 2022 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 444.66% in 2023, down 0.0% in 2023.
• Tracing ROIV's Invested Capital over 3 years: stood at $40.0 million in 2022, then soared by 388.24% to $195.3 million in 2023, then plunged by 79.52% to $40.0 million in 2024.
• The last three Invested Capital figures came in at $40.0 million (Q2 2024), $40.0 million (Q1 2024), and $195.3 million (Q4 2023), per Business Quant data.